Dr. Parker is a Team Leader at the Peter MacCallum Cancer Centre, Australia, heading the Tumour Microenvironment group. Through her work in the breast cancer metastasis field, she has been awarded a number of fellowships and grants, including an NHMRC Career Development Award (CDA1). Dr Parker’s primary research focus is to utilize models of breast cancer combined with assessment of human cancers to identify key molecular mechanisms of spread to distant tissues. Her ultimate aim is to develop novel prognostic markers and targeted therapies to predict metastasis in patients and prevent spread before macrometastases occur. Her recent work has revealed that tumour cell-immune cell crosstalk is essential in preventing metastatic spread to bone and her group currently focuses on the pathways and mechanisms essential for restoring tumour immune surveillance to prevent metastasis.
Abstracts this author is presenting: